Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung CancerBy [email protected] / November 4, 2024 Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer
